Howard J. Worman, MD, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Worman H.; Blood Donors with Antibody to Hepatitis C Virus. Ann Intern Med. 1996;124:930-931. doi: 10.7326/0003-4819-124-10-199605150-00028
Download citation file:
Published: Ann Intern Med. 1996;124(10):930-931.
TO THE EDITOR:
The clinical presentation of patients with chronic hepatitis C can range from the absence of symptoms to the presence of cirrhosis and hepatocellular carcinoma. Several studies on the natural history of hepatitis C have been published [1-3], but conflicting data exist on the presentation and progression of patients with this disease. Thus, physicians are often unsure about prognosis, management, and treatment. In this regard, discrepancies in the results of two recent studies [4, 5] deserve comment.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only